Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D1RU
|
||||
Former ID |
DNC012021
|
||||
Drug Name |
Indol-1-yl-pyridin-4-yl-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [534087] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H11N3
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C=CN2NC3=CC=NC=C3
|
||||
InChI |
1S/C13H11N3/c1-2-4-13-11(3-1)7-10-16(13)15-12-5-8-14-9-6-12/h1-10H,(H,14,15)
|
||||
InChIKey |
YFXZWVUZIPQSKX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Alpha-2C adrenergic receptor | Target Info | Inhibitor | [534087] | |
Alpha-2A adrenergic receptor | Target Info | Inhibitor | [534087] | ||
Alpha-2B adrenergic receptor | Target Info | Inhibitor | [534087] | ||
PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP00002:Alpha adrenergic receptor signaling pathwayP00002:Alpha adrenergic receptor signaling pathway | |||||
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.